Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
20–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients must have schizophrenia that meets disease diagnostic criteria in DSM-IV-TR
Patients must be inpatients during the study
Patients must have a minimum total score of no less than 14 on the five items of the PANSS-EC and at least one individual item score of no less than 4 using the 1-7 scoring system prior to the first injection of study drug
You may not be if
Patients who have a known history of diabetes mellitus.
Patients who have received treatment with antipsychotics or other prohibited concomitant medicines within 2 hours prior to the first IM study drug administration
Patients who have had treatment with benzodiazepines within 4 hours prior to first IM study drug administration.
Clareo Health | A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia
